AI-generated summary
The authors report a double-blind, placebo-controlled randomized trial of 60 patients with chronic testicular pain, comparing red (650 nm) and infrared (820 nm) low-level laser with a placebo laser. Both active groups showed significant pain reduction and improved sexual satisfaction at 6 and 12 weeks compared with control. The authors conclude the therapy is safe and useful, though the abstract itself reports only one trial with 20 patients per group.
- Participants
- 60
- Who or what was studied
- Patients with chronic testicular pain
- Wavelengths
- 650, 820 nm
- Limits stated in the abstract
- The abstract reports a single trial with 20 patients per group and does not describe long-term follow-up beyond 12 weeks.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sbmu.ac.ir.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 650 nm, 820 nm
- Power
- 50 mW, 100 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Placebo-controlled. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.